News
Articles
Browse events, publications and articles relating to cell culture and ExcellGene’s work.
On-demand webinar
Newly Available on-demand webinar! How to quantify AAV particle production from transfected HEK cellsJoin ExcellGene SA, a company providing AAV production processes and develops such processes for its clients, in a free webinar. Dr. Yoann Saucereau, a research...
A superior HEK cell line for AAV production
A superior HEK cell line for AAV productionWriter's Insight Derived from ExcellGene's HEKExpress® cells, a widely used cell system known for its transient and stable protein expression, a new host system with superior performance has been developed. This innovative...
EXCELLGENE, Switzerland, and LOTTE BIOLOGICS, South Korea, Announce a Collaboration for Cell Line Development and Manufacturing of Biologics.
EXCELLGENE, Switzerland, and LOTTE BIOLOGICS, South Korea, Announce a Collaboration for Cell Line Development and Manufacturing of Biologics.PRESS RELEASETues 4th April, 2023LOTTE BIOLOGICS and EXCELLGENE today announced the signing of a Memorandum of Understanding to...
Affordable SARS-CoV-2 protein vaccines for the pandemic endgame
Innovation in Vaccine Manufacturing
Download the PDF Innovation in Vaccine Manufacturing
Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney.
Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney Press release Tues 26th July, 2022 Monthey, Switzerland -PRESS RELEASE- ExcellGene SA, privately held and founded 2001, offers services...
Excellgene SA Symposium on Modern Vaccines
Dr. Kiseljak, ExcellGene COO To Drive Recombinant Protein Expression
Download the PDF
CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development
Download the PDF For your convenience, this overview of our cGMP cell banking services is available as a downloadable PDF.
Manufacturing SARS-CoV-2 Omicron spike protein in grams
ExcellGene’s Ebola Vaccine Research Efforts Enable Development of SARS-CoV-2 Trimeric Spike Proteins CHO-based Process Enhances Expression of Complex Trimeric Proteins for Rapid Vaccine Development CHO Cells Can be Used to Quickly Produce Complex Trimeric Proteins...
Twenty Years
Manufacturing SARS-CoV-2 Omicron spike protein in grams
ExcellGene to Manufacture SARS-CoV-2 Trimeric Omicron Spike Protein, Optimized for Subunit Vaccine, Diagnostic and Drug DevelopmentCHO-based cGMP Process Allows for Gram Quantities of Omicron and Delta Spike ProteinsPress release MONTHEY, Switzerland, December 15,...
Naming CHO Cells for Bio-manufacturing
Introduction Over the last 3 decades, CHO cells have become the most popular cell line for production of recombinant proteins for human therapy. In fact, nine of the world's 15 top selling drugs are protein therapeutics derived from CHO cells—with 76 Billion US...
Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens (Summary)
From DNA to Therapeutic Protein in CHO Cells
Free Virtual Talk and Q&A: From DNA to Therapeutic Protein in CHO Cells
Subunit Vaccine Production in CHO cells: Development of an Efficacious Ebola Virus Vaccine
Subunit Vaccine Production in CHO cells: Development of an Efficacious Ebola Virus Vaccine Candidate Authors Florian M. Wurm PhD, Prof. Emeri. Chief Scientific Officer, Founder Divor Kiseljak PhD Director of Process Science 20th April 2020 | Last updated: 3rd August...
CHO Quasispecies – Implications for Manufacturing Processes
Introduction Chinese hamster ovary (CHO) cells are, today, the gold standard for the manufacturing of therapeutic proteins. The overall value of products derived from these cells exceeds 50 billion US $ annually, and significant research and development efforts are...
Single Use Bioreactors & Disposable Process Materials, How-To & Issues
Smart Strategies to Enhance Productivity, Improve Titers, Cell Culture Performance and Product Quality @ BioProduction 2019
Cloning of CHO Cells, Productivity and Genetic Stability – a Discussion
Introduction The sheer diversity of genomic and phenotypic variation of CHO cell populations (and of other immortalized cell lines) is poorly understood and possibly underestimated. Also, mechanisms resulting in mutational evolution of populations in cell culture in...
New White Paper: Cloning of CHO Cells, Productivity and Genetic Stability, Best Paper Award, Keynote Lecture on CHO
A New Ebola Vaccine: ExcellGene in a Euro-Swiss Initiative
Future of Transient Gene Expression Keynote @ PEGS Europe 2018
Transient Gene Expression: Paper Submissions Welcome
Better media and feeds for higher CHO yield
Better media and feeds for higher CHO yield In an article written in November 2017 by Dr. Angelo DePalma in Genetic Engineering and Biotechnology News (GEN), ExcellGene and CSO Prof. F. Wurm were referred to discussing the benefits of better media and feeds as the...